is tirzepatide a glp-1 or 2 Frontiers Understand GLP-1/GIP Dual Agonist Tirzepatide

M.KreusserK

GLP-1 drugs act on satiety control and work on the brain regions to control appetite and slow gastric emptying, thereby helping reduce glucose in the blood

While prevalence data for subclinical gut overgrowth is difficult to quantify precisely because it is underdiagnosed functional medicine practitioners report that it is among the most common root-cause findings in patients presenting with chronic fatigue, irritable bowel syndrome, and treatment-resistant mood disorders

Further studies assessing the temporal relation between glucose control, weight loss, and dermatologic improvement following initiation of GLP-1RAs are needed to determine the efficacy of GLP-1RAs and the mechanism by which they act